JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
iShares JPMorgan EM High Yield Bond ETF
EMHY
$639M
| $3.64M | ﹤0.01% |
72,894
-9,118
| -11% | -$458K |
|
2802
Natural Gas Services Group
NGS
$474M
| $3.64M | ﹤0.01% |
138,801
-2,124
| -2% | -$56.6K |
|
|
PGEM
2803
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $3.64M | ﹤0.01% |
196,460
+37,283
| +23% | +$647K |
|
2804
Radware
RDWR
$1.25B
| $3.62M | ﹤0.01% |
186,528
+59,294
| +47% | +$1.12M |
|
|
CSFL
2805
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $3.61M | ﹤0.01% |
140,416
-18,822
| -12% | -$502K |
|
|
USCR
2806
DELISTED
U S Concrete, Inc.
USCR
| $3.61M | ﹤0.01% |
43,176
+30,121
| +231% | +$2.37M |
|
2807
S&T Bancorp
STBA
$1.82B
| $3.61M | ﹤0.01% |
90,705
+24,139
| +36% | +$977K |
|
2808
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
| $3.6M | ﹤0.01% |
150,000
| – | – |
|
2809
PUT
Cognizant
CTSH
$26.7B
| $3.6M | ﹤0.01% |
50,700
-12,200
| -19% | -$892K |
|
|
CCEC
2810
Capital Clean Energy Carriers
CCEC
$1.36B
| $3.6M | ﹤0.01% |
153,123
+10,843
| +8% | +$255K |
|
|
ALNA
2811
DELISTED
Allena Pharmaceuticals
ALNA
| $3.6M | ﹤0.01% |
+357,843
| New | +$4.41M |
|
2812
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$440M
| $3.58M | ﹤0.01% |
34,237
+14,534
| +74% | +$1.5M |
|
2813
SFL Corp
SFL
$1.61B
| $3.58M | ﹤0.01% |
230,779
+148,363
| +180% | +$2.23M |
|
|
IMDZ
2814
DELISTED
Immune Design Corp.
IMDZ
| $3.58M | ﹤0.01% |
916,589
+411,914
| +82% | +$2.24M |
|
2815
Dr. Reddy's Laboratories
RDY
$10.3B
| $3.56M | ﹤0.01% |
474,580
-1,011,800
| -68% | -$7.29M |
|
|
SNCR
2816
DELISTED
Synchronoss Technologies
SNCR
| $3.56M | ﹤0.01% |
44,277
-767
| -2% | -$74.1K |
|
2817
CALL
Bunge Global
BG
$21.7B
| $3.56M | ﹤0.01% |
+53,100
| New | +$3.61M |
|
2818
Forward Air
FWRD
$682M
| $3.56M | ﹤0.01% |
61,966
+23,422
| +61% | +$1.34M |
|
2819
GATX Corp
GATX
$6.33B
| $3.56M | ﹤0.01% |
57,181
+10,795
| +23% | +$656K |
|
2820
Syndax Pharmaceuticals
SNDX
$1.7B
| $3.55M | ﹤0.01% |
405,360
-14,310
| -3% | -$142K |
|
|
QADA
2821
DELISTED
QAD Inc.
QADA
| $3.55M | ﹤0.01% |
91,354
-29,724
| -25% | -$1.12M |
|
2822
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $3.55M | ﹤0.01% |
+119,370
| New | +$3.57M |
|
2823
Lakeland Financial Corp
LKFN
$1.56B
| $3.54M | ﹤0.01% |
72,955
+2,785
| +4% | +$136K |
|
2824
HNI Corp
HNI
$3.56B
| $3.52M | ﹤0.01% |
91,394
+13,166
| +17% | +$482K |
|
|
XYZ
2825
PUT
Block Inc
XYZ
$49.9B
| $3.5M | ﹤0.01% |
+101,000
| New | +$3.7M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.